The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2022 | The use of single-cell RNA sequencing to analyze patient response to CAR-T
Juan Du
• 13 Jun 2022
Juan Du, MD, Changzheng Hospital, The Second Military Medical University, Shanghai, China, briefly discusses a study which investigated the use of single-cell RNA sequencing to analyze patient response to CAR-T therapy, and the value of using single-cell sequencing in future studies. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
